Prebet T, Fenaux P, Vey N; Groupe Francophone des Myelodysplasies (GFM).
Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system.
Haematologica. 2016 Oct;101(10):e427-e428. No abstract available.
https://www.ncbi.nlm.nih.gov/pubmed/27694503